p21 limits S phase DNA damage caused by the Wee1 inhibitor MK1775
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
The Wee1 inhibitor MK1775 (AZD1775) is currently being tested in clinical trials for cancer treatment. Here, we show that the p53 target and CDK inhibitor p21 protects against MK1775-induced DNA damage during S-phase. Cancer and normal cells deficient for p21 (HCT116 p21-/-, RPE p21-/-, and U2OS transfected with p21 siRNA) showed higher induction of the DNA damage marker γH2AX in S-phase in response to MK1775 compared to the respective parental cells. Furthermore, upon MK1775 treatment the levels of phospho-DNA PKcs S2056 and phospho-RPA S4/S8 were higher in the p21 deficient cells, consistent with increased DNA breakage. Cell cycle analysis revealed that these effects were due to an S-phase function of p21, but MK1775-induced S-phase CDK activity was not altered as measured by CDK-dependent phosphorylations. In the p21 deficient cancer cells MK1775-induced cell death was also increased. Moreover, p21 deficiency sensitized to combined treatment of MK1775 and the CHK1-inhibitor AZD6772, and to the combination of MK1775 with ionizing radiation. These results show that p21 protects cancer cells against Wee1 inhibition and suggest that S-phase functions of p21 contribute to mediate such protection. As p21 can be epigenetically downregulated in human cancer, we propose that p21 levels may be considered during future applications of Wee1 inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Intriguingly, the downregulation of p21 also interferes with the optimal processivity of DNA replication [79,83,86].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“which demonstrate that endogenous p21, and specifically the fraction expressed in the S phase, has an important role in the control of unperturbed and damaged DNA replication.”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
MicroRNA-93 promotes cell proliferation by directly targeting P21 in osteosarcoma cells
He, Y., & Yu, B. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4204 · Cited by 29
RetractedRequirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
PCNA, the Maestro of the Replication Fork
Moldovan, G.-L., Pfander, B., & Jentsch, S. (2007) · Cell · doi:10.1016/j.cell.2007.05.003 · Cited by 1,796 · cited 1×
“Furthermore, p21 has a strong affinity for PCNA, and prevents replication by blocking the interaction between PCNA and factors that are necessary for replication, such as replicative DNA polymerases [21,22].”
BackgroundThe p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Radiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242
Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.
Karimian, A., Ahmadi, Y., & Yousefi, B. (2016) · DNA Repair · doi:10.1016/j.dnarep.2016.04.008 · Cited by 1,110 · cited 3×
“The p53 target and CDK inhibitor p21 plays a fundamental part in regulating cell cycle progression, as well as cellular senescence and apoptosis [11].”
BackgroundATR prohibits replication catastrophe by preventing global exhaustion of RPA
Toledo, L. I., Altmeyer, M., Rask, M.-B., Lukas, C., Larsen, D. H., Povlsen, L. K., Bekker-Jensen, S., Mailand, N., Bartek, J., & Lukas, J. (2013) · Cell · doi:10.1016/j.cell.2013.10.043 · Cited by 911
Inactivation of the p34 cdc2 -Cyclin B Complex by the Human WEE1 Tyrosine Kinase
Parker, L. L., & Piwnica-Worms, H. (1992) · Science · doi:10.1126/science.1384126 · Cited by 716
MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression
Ivanovska, I., Ball, A. S., Diaz, R. L., Magnus, J. F., Kibukawa, M., Schelter, J. M., Kobayashi, S. V., Lim, L., Burchard, J., Jackson, A. L., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01977-07 · Cited by 561
Cited by
Shamloo, B., & Usluer, S. (2019) · Cancers · doi:10.3390/cancers11081178 · Cited by 336
“p21−/− HCT116 Increased apoptosis and cell death with treatment of ginseng, imatinib and gefitinib, pyrazolo(1,5-a)pyrimidine, microtubule inhibitors, MK1775 checkpoint inhibitor [65] [66] [67] [68] [69] p21−/− MMTV-ras Higher S-phase fractions, increased spontaneous apoptosis [51] p21−/− MMTV-myc Lower S-phase fracti…”
BackgroundBasit, A., Cho, M.-G., Kim, E.-Y., Kwon, D., Kang, S.-J., & Lee, J.-H. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0416-y · Cited by 118
CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication
Mansilla, S. F., De La Vega, M. B., Calzetta, N. L., Siri, S. O., & Gottifredi, V. (2020) · Genes · doi:10.3390/genes11060593 · Cited by 114
Ticli, G., Cazzalini, O., Stivala, L. A., & Prosperi, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137058 · Cited by 76
WEE1 kinase protects the stability of stalled DNA replication forks by limiting CDK2 activity
Elbæk, C. R., Petrosius, V., Benada, J., Erichsen, L., Damgaard, R. B., & Sørensen, C. S. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110261 · Cited by 64
Metadata
- Authors
- Hauge, S., Macurek, L., & Syljuåsen, R. G.
- Affiliations
- Oslo University Hospital (NO)
- Department of Cancer Cell Biology, Institute of Molecular Genetics of the ASCR, Prague, Czech Republic
- Corresponding author
- Syljuåsen, Randi G.
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2019-04-03
- Volume
- 18
- Issue
- 8
- Pages
- 834-847
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- PMC
- PMC6527284
- OpenAlex
- W2929688087
- Cited by
- 30
- References
- 48
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 6 · 2022: 6 · 2021: 2 · 2020: 5 · 2019: 2
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell Cycle (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Helse Sør-Øst RHF (2016114)
- Kreftforeningen (62320, 198018)
- Grant Agenzy of the Czech Republic (17-04742S)
- EEA Czexg-Norwegian Research Programme (7F14061)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p21, MK-1775, AZD1775, WEE1 inhibitor, S phase, DNA damage, γH2AX, CDK inhibition, DNA double-strand breaks, DNA-PKcs, RPA, p53 target genes, cell death, CHK1 inhibitor, ionizing radiation, cancer therapy
- MeSH terms
- Checkpoint Kinase 1, Antineoplastic Agents, Cell Survival, DNA Damage, Humans, Neoplasms, Phosphorylation, Protein-Tyrosine Kinases, Pyrazoles, Pyrimidinones, Transfection, Cell Cycle Proteins, Cyclin-Dependent Kinases, RNA, Small Interfering, HCT116 Cells, Cyclin-Dependent Kinase Inhibitor p21, S Phase Cell Cycle Checkpoints
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: p21 limits S phase DNA damage caused by the Wee1 inhibitor MK1775. https://app.cochat.ai/papers/10.1080/15384101.2019.1593649
- The paper
- Hauge, S., Macurek, L., & Syljuåsen, R. G. (2019). p21 limits S phase DNA damage caused by the Wee1 inhibitor MK1775. Cell Cycle. https://doi.org/10.1080/15384101.2019.1593649
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.